Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Prevalence and Risk Factors of Thyroid Dysfunction in Older Adults in the Community.

Diab N, Daya NR, Juraschek SP, Martin SS, McEvoy JW, Schultheiß UT, Köttgen A, Selvin E.

Sci Rep. 2019 Sep 11;9(1):13156. doi: 10.1038/s41598-019-49540-z.

2.

Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.

Juraschek SP, Daya N, Appel LJ, Miller ER 3rd, Matsushita K, Michos ED, Windham BG, Ballantyne CM, Selvin E.

J Am Geriatr Soc. 2019 Sep;67(9):1795-1802. doi: 10.1111/jgs.16041. Epub 2019 Jul 10.

PMID:
31493355
3.

United States Registered Nurse Workforce Report Card and Shortage Forecast.

Juraschek SP, Zhang X, Ranganathan V, Lin VW.

Am J Med Qual. 2019 Sep/Oct;34(5):473-481. doi: 10.1177/1062860619873217.

PMID:
31479295
4.

Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT Trial.

Juraschek SP, Simpson LM, Davis BR, Beach JL, Ishak A, Mukamal KJ.

Hypertension. 2019 Oct;74(4):1033-1040. doi: 10.1161/HYPERTENSIONAHA.119.13445. Epub 2019 Sep 3.

PMID:
31476905
5.

Healthy diet reduces markers of cardiac injury and inflammation regardless of macronutrients: Results from the OmniHeart trial.

Kovell LC, Yeung EH, Miller ER 3rd, Appel LJ, Christenson RH, Rebuck H, Schulman SP, Juraschek SP.

Int J Cardiol. 2019 Aug 2. pii: S0167-5273(19)30030-0. doi: 10.1016/j.ijcard.2019.07.102. [Epub ahead of print]

PMID:
31447226
6.

Impact of Clinic-Based Blood Pressure Approaches on Blood Pressure Measurement.

Juraschek SP, Ishak A, Mukamal KJ, Cohen ML, Beach JL.

Am J Hypertens. 2019 Jul 27. pii: hpz118. doi: 10.1093/ajh/hpz118. [Epub ahead of print]

PMID:
31350541
7.

Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey.

O'Brien CW, Juraschek SP, Wee CC.

Ann Intern Med. 2019 Jul 23. doi: 10.7326/M19-0953. [Epub ahead of print] No abstract available.

PMID:
31330542
8.

Effects of the DASH Diet and Sodium Intake on Bloating: Results From the DASH-Sodium Trial.

Peng AW, Juraschek SP, Appel LJ, Miller ER 3rd, Mueller NT.

Am J Gastroenterol. 2019 Jul;114(7):1109-1115. doi: 10.14309/ajg.0000000000000283.

PMID:
31206400
9.

Dose-dependent effects of lifestyle interventions on blood lipid levels: Results from the PREMIER trial.

Dudum R, Juraschek SP, Appel LJ.

Patient Educ Couns. 2019 Oct;102(10):1882-1891. doi: 10.1016/j.pec.2019.05.005. Epub 2019 May 18.

PMID:
31153659
10.

Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.

Selvin E, Wang D, McEvoy JW, Juraschek SP, Lazo M, Hamet P, Cooper ME, Marre M, Williams B, Harrap S, Chalmers J, Woodward M.

Diabetes Obes Metab. 2019 Aug;21(8):2017-2023. doi: 10.1111/dom.13755. Epub 2019 May 29.

PMID:
31050156
11.

Association of Orthostatic Hypotension Timing With Clinical Events in Adults With Diabetes and Hypertension: Results From the ACCORD Trial.

Juraschek SP, Lipsitz LA, Beach JL, Mukamal KJ.

Am J Hypertens. 2019 Jun 11;32(7):684-694. doi: 10.1093/ajh/hpz015.

PMID:
30715100
12.

Effects of sodium intake on postural lightheadedness: Results from the DASH-sodium trial.

Peng AW, Appel LJ, Mueller NT, Tang O, Miller ER 3rd, Juraschek SP.

J Clin Hypertens (Greenwich). 2019 Mar;21(3):355-362. doi: 10.1111/jch.13487. Epub 2019 Jan 28.

13.

Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel.

Muntner P, Einhorn PT, Cushman WC, Whelton PK, Bello NA, Drawz PE, Green BB, Jones DW, Juraschek SP, Margolis KL, Miller ER 3rd, Navar AM, Ostchega Y, Rakotz MK, Rosner B, Schwartz JE, Shimbo D, Stergiou GS, Townsend RR, Williamson JD, Wright JT Jr, Appel LJ; 2017 National Heart, Lung, and Blood Institute Working Group.

J Am Coll Cardiol. 2019 Jan 29;73(3):317-335. doi: 10.1016/j.jacc.2018.10.069. Review.

PMID:
30678763
14.

Comparison of automated clinical and research blood pressure measurements: Implications for clinical practice and trial design.

Tang O, Juraschek SP, Appel LJ, Cooper LA, Charleston J, Boonyasai RT, Carson KA, Yeh HC, Miller ER 3rd.

J Clin Hypertens (Greenwich). 2018 Dec;20(12):1676-1682. doi: 10.1111/jch.13412. Epub 2018 Nov 7.

15.

Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease.

Juraschek SP, Appel LJ, Miller ER 3rd, Mukamal KJ, Lipsitz LA.

Hypertension. 2018 Oct;72(4):986-993. doi: 10.1161/HYPERTENSIONAHA.118.11337.

PMID:
30354704
16.

Rationale and design of the Study To Understand Fall Reduction and Vitamin D in You (STURDY): A randomized clinical trial of Vitamin D supplement doses for the prevention of falls in older adults.

Michos ED, Mitchell CM, Miller ER 3rd, Sternberg AL, Juraschek SP, Schrack JA, Szanton SL, Walston JD, Kalyani RR, Plante TB, Christenson RH, Shade D, Tonascia J, Roth DL, Appel LJ; STURDY Collaborative Research Group.

Contemp Clin Trials. 2018 Oct;73:111-122. doi: 10.1016/j.cct.2018.08.004. Epub 2018 Aug 20.

PMID:
30138718
17.

Comparison of Frequency of Atherosclerotic Cardiovascular and Safety Events With Systolic Blood Pressure <120mm Hg Versus 135-139mm Hg in a Systolic Blood Pressure Intervention Trial Primary Prevention Subgroup.

Plante TB, Juraschek SP, Miller ER 3rd, Appel LJ, Cushman M, Littenberg B.

Am J Cardiol. 2018 Oct 1;122(7):1185-1190. doi: 10.1016/j.amjcard.2018.06.041. Epub 2018 Jul 4.

PMID:
30115425
18.

Design Features of Randomized Clinical Trials of Vitamin D and Falls: A Systematic Review.

Tang O, Juraschek SP, Appel LJ.

Nutrients. 2018 Jul 26;10(8). pii: E964. doi: 10.3390/nu10080964. Review.

19.

Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline.

Rawlings AM, Juraschek SP, Heiss G, Hughes T, Meyer ML, Selvin E, Sharrett AR, Windham BG, Gottesman RF.

Neurology. 2018 Aug 21;91(8):e759-e768. doi: 10.1212/WNL.0000000000006027. Epub 2018 Jul 25.

20.

Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle-Aged Adults.

Juraschek SP, Daya N, Appel LJ, Miller ER 3rd, McEvoy JW, Matsushita K, Ballantyne CM, Selvin E.

J Am Heart Assoc. 2018 May 7;7(10). pii: e008884. doi: 10.1161/JAHA.118.008884.

21.

Reply: The Role of Salt Reduction in the Management of Hypertension.

Juraschek SP, Miller ER 3rd, Appel LJ.

J Am Coll Cardiol. 2018 Apr 10;71(14):1598-1599. doi: 10.1016/j.jacc.2018.02.012. No abstract available.

22.

Late life socioeconomic status and hypertension in an aging cohort: the Atherosclerosis Risk in Communities Study.

McDoom MM, Palta P, Vart P, Juraschek SP, Kucharska-Newton A, Diez Roux AV, Coresh J.

J Hypertens. 2018 Jun;36(6):1382-1390. doi: 10.1097/HJH.0000000000001696.

23.

Orthostatic Hypotension and Symptoms in the AASK Trial.

Juraschek SP, Miller ER 3rd, Appel LJ.

Am J Hypertens. 2018 May 7;31(6):665-671. doi: 10.1093/ajh/hpy010.

24.

Use of online recruitment strategies in a randomized trial of cancer survivors.

Juraschek SP, Plante TB, Charleston J, Miller ER, Yeh HC, Appel LJ, Jerome GJ, Gayles D, Durkin N, White K, Dalcin A, Hermosilla M.

Clin Trials. 2018 Apr;15(2):130-138. doi: 10.1177/1740774517745829. Epub 2018 Jan 24.

25.

Predictors of Insulin Initiation in Patients with Type 2 Diabetes: An Analysis of the Look AHEAD Randomized Trial.

Pilla SJ, Yeh HC, Juraschek SP, Clark JM, Maruthur NM.

J Gen Intern Med. 2018 Jun;33(6):839-846. doi: 10.1007/s11606-017-4282-9. Epub 2018 Jan 19.

26.

Effects of a Dietary Approach to Stop Hypertension (DASH) Diet Intervention on Serum Uric Acid in African Americans With Hypertension.

Juraschek SP, White K, Tang O, Yeh HC, Cooper LA, Miller ER 3rd.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1509-1516. doi: 10.1002/acr.23515. Epub 2018 Aug 21.

PMID:
29342506
27.

Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.

Juraschek SP, Miller ER 3rd, Weaver CM, Appel LJ.

J Am Coll Cardiol. 2017 Dec 12;70(23):2841-2848. doi: 10.1016/j.jacc.2017.10.011. Epub 2017 Nov 12.

28.

Chronic kidney disease: Intensive blood pressure reduction lowers mortality in CKD.

Juraschek SP, Appel LJ.

Nat Rev Nephrol. 2018 Jan;14(1):5-6. doi: 10.1038/nrneph.2017.154. Epub 2017 Nov 7. No abstract available.

29.

Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet.

Juraschek SP, Woodward M, Sacks FM, Carey VJ, Miller ER 3rd, Appel LJ.

Hypertension. 2017 Nov;70(5):923-929. doi: 10.1161/HYPERTENSIONAHA.117.10017.

30.

Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.

Juraschek SP, Appel LJ, Miller ER 3rd.

Am J Hypertens. 2017 Sep 1;30(9):871-875. doi: 10.1093/ajh/hpx113.

31.

Association of History of Dizziness and Long-term Adverse Outcomes With Early vs Later Orthostatic Hypotension Assessment Times in Middle-aged Adults.

Juraschek SP, Daya N, Rawlings AM, Appel LJ, Miller ER 3rd, Windham BG, Griswold ME, Heiss G, Selvin E.

JAMA Intern Med. 2017 Sep 1;177(9):1316-1323. doi: 10.1001/jamainternmed.2017.2937.

32.

Relation of Exercise Capacity to Risk of Development of Diabetes in Patients on Statin Therapy (the Henry Ford Exercise Testing Project).

Shaya GE, Juraschek SP, Feldman DI, Brawner CA, Ehrman JK, Keteyian SJ, Al-Mallah MH, Blaha MJ.

Am J Cardiol. 2017 Sep 1;120(5):769-773. doi: 10.1016/j.amjcard.2017.05.048. Epub 2017 Jun 15.

PMID:
28716336
33.

Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Appel LJ, Christenson RH, Sacks FM, Selvin E.

Diabet Med. 2017 Oct;34(10):1407-1413. doi: 10.1111/dme.13391. Epub 2017 Jul 9.

34.

DASH diet and change in serum uric acid over time.

Tang O, Miller ER 3rd, Gelber AC, Choi HK, Appel LJ, Juraschek SP.

Clin Rheumatol. 2017 Jun;36(6):1413-1417. doi: 10.1007/s10067-017-3613-x. Epub 2017 Mar 31.

35.

Pilot study of the effect of cholecalciferol supplementation on hepcidin in children with chronic kidney disease: Results of the D-fense Trial.

Atkinson MA, Juraschek SP, Bertenthal MS, Detrick B, Furth SL, Miller ER 3rd.

Pediatr Nephrol. 2017 May;32(5):859-868. doi: 10.1007/s00467-016-3563-6. Epub 2016 Dec 24.

36.

Opposing effects of sodium intake on uric acid and blood pressure and their causal implication.

Juraschek SP, Choi HK, Tang O, Appel LJ, Miller ER 3rd.

J Am Soc Hypertens. 2016 Dec;10(12):939-946.e2. doi: 10.1016/j.jash.2016.10.012. Epub 2016 Nov 11.

37.

Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Selvin E, Carey VJ, Appel LJ, Christenson RH, Sacks FM.

BMJ Open Diabetes Res Care. 2016 Nov 14;4(1):e000276. eCollection 2016.

38.

Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial.

Chang AR, Miller ER 3rd, Anderson CA, Juraschek SP, Moser M, White K, Henry B, Krekel C, Oh S, Charleston J, Appel LJ.

Am J Kidney Dis. 2017 Feb;69(2):200-209. doi: 10.1053/j.ajkd.2016.08.029. Epub 2016 Nov 16.

39.

Orthostatic Hypotension in Middle-Age and Risk of Falls.

Juraschek SP, Daya N, Appel LJ, Miller ER 3rd, Windham BG, Pompeii L, Griswold ME, Kucharska-Newton A, Selvin E.

Am J Hypertens. 2017 Feb;30(2):188-195. doi: 10.1093/ajh/hpw108. Epub 2016 Sep 16.

40.

Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid.

Juraschek SP, Gelber AC, Choi HK, Appel LJ, Miller ER 3rd.

Arthritis Rheumatol. 2016 Dec;68(12):3002-3009. doi: 10.1002/art.39813.

41.

Effect of glycemic index and carbohydrate intake on kidney function in healthy adults.

Juraschek SP, Chang AR, Appel LJ, Anderson CA, Crews DC, Thomas L, Charleston J, Miller ER 3rd.

BMC Nephrol. 2016 Jul 8;17(1):70. doi: 10.1186/s12882-016-0288-5.

42.

The association of clinical indication for exercise stress testing with all-cause mortality: the FIT Project.

Kim J, Al-Mallah M, Juraschek SP, Brawner C, Keteyian SJ, Nasir K, Dardari ZA, Blumenthal RS, Blaha MJ.

Arch Med Sci. 2016 Apr 1;12(2):303-9. doi: 10.5114/aoms.2016.59255. Epub 2016 Apr 12.

43.

Sex Differences in Cardiorespiratory Fitness and All-Cause Mortality: The Henry Ford ExercIse Testing (FIT) Project.

Al-Mallah MH, Juraschek SP, Whelton S, Dardari ZA, Ehrman JK, Michos ED, Blumenthal RS, Nasir K, Qureshi WT, Brawner CA, Keteyian SJ, Blaha MJ.

Mayo Clin Proc. 2016 Jun;91(6):755-62. doi: 10.1016/j.mayocp.2016.04.002. Epub 2016 May 6.

44.

Response to Letter Regarding Article, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project".

Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH.

Circulation. 2015 Dec 22;132(25):e395. doi: 10.1161/CIRCULATIONAHA.115.018758. No abstract available.

PMID:
26700015
45.

Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid Levels: The OmniCarb Randomized Clinical Trial.

Juraschek SP, McAdams-Demarco M, Gelber AC, Sacks FM, Appel LJ, White KJ, Miller ER 3rd.

Arthritis Rheumatol. 2016 May;68(5):1281-9. doi: 10.1002/art.39527.

46.

The Gamma Gap and All-Cause Mortality.

Juraschek SP, Moliterno AR, Checkley W, Miller ER 3rd.

PLoS One. 2015 Dec 2;10(12):e0143494. doi: 10.1371/journal.pone.0143494. eCollection 2015.

47.

Response to Comment on Juraschek et al. Cardiorespiratory Fitness and Incident Diabetes: The FIT (Henry Ford ExercIse Testing) Project. Diabetes Care 2015;38:1075-1081.

Juraschek SP, Blaha MJ, Al-Mallah MH.

Diabetes Care. 2015 Nov;38(11):e194-5. doi: 10.2337/dci15-0007. No abstract available.

PMID:
26494817
48.

Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010.

Kovell LC, Juraschek SP, Russell SD.

PLoS One. 2015 Jul 14;10(7):e0132228. doi: 10.1371/journal.pone.0132228. eCollection 2015.

49.

Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project.

Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH.

Circulation. 2015 May 26;131(21):1827-34. doi: 10.1161/CIRCULATIONAHA.114.014833. Epub 2015 Apr 22.

PMID:
25904645
50.

Cardiorespiratory fitness and incident diabetes: the FIT (Henry Ford ExercIse Testing) project.

Juraschek SP, Blaha MJ, Blumenthal RS, Brawner C, Qureshi W, Keteyian SJ, Schairer J, Ehrman JK, Al-Mallah MH.

Diabetes Care. 2015 Jun;38(6):1075-81. doi: 10.2337/dc14-2714. Epub 2015 Mar 12.

PMID:
25765356

Supplemental Content

Loading ...
Support Center